Mapping large numbers of results may take a few moments.
Search Results
Showing 301 - 350 of 414 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company Polaris QB Inc. | Activity: Research and Development | Company Description POLARISqb uses emerging biological data, cloud and quantum computing and artificial intelligence to produce drug blueprints to speed the lead time for preclinical drug candidates. | Location Durham | |
Company Praetego Inc. | Activity: Research and Development | Company Description Praetego is preclinical stage pharmaceutical company committed to improving health outcomes by addressing chronic diseases of aging, starting with Alzheimer’s Disease. Praetego’s novel small molecules inhibit a systemic driver of oxidative stress at the initiation of pathology. | Location Research Triangle Park | |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Durham | |
Company Priovant Therapeutics | Activity: Research and Development | Company Description Priovant is developing and commercializing targeted therapeutics for patients with severe autoimmune disease. | Location Durham | |
Company Pruvyc Pharma LLC | Activity: Research and Development | Company Description Pruvyc Pharma is developing a method for treating pruritus. | Location Cary | |
Company Qatch Technologies LLC | Activity: Research and Development | Company Description QATCH develops a microfluidic viscometer that screens injectability and manufacturability of biopharmaceutical formulations in preclinical drug development. | Location Durham | |
Company QuatroBio LLC | Activity: Research and Development | Company Description QuatroBio provides oversight and strategic direction to several closely held drug development companies. | Location Morrisville | |
Company Qura Therapeutics LLC | Activity: Research and Development | Company Description Qura Therapeutics is discovering therapeutics for curing HIV/AIDS. Qura is a joint venture between ViV Healthcare and UNC-CH and provides financial, material and development support for therapies that emerge from research at the UNC HIV Cure Center. | Location Chapel Hill | |
Company RAIN Scientific Inc. | Activity: Research and Development | Company Description Rain Scientific is developing technologies to combat pathogens such as COVID-19 and drug resistant bacteria. | Location Cornelius | |
Company RainBio Inc. | Activity: Research and Development | Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. | Location Raleigh | |
Company Reactive Biosciences Inc. | Activity: Research and Development | Company Description Reactive Biosciences uses a boron-based discovery platform to discover and develop new medicines. | Location Durham | |
Company READDI Inc. | Activity: Research and Development | Company Description Rapidly Emerging Antiviral Drug Development Initiative (READDI) is a public-private partnership that develops broad-spectrum antiviral therapies for COVID-19 and other emerging viral threats. | Location Chapel Hill | |
Company Regennova Inc. | Activity: Research and Development | Company Description Regennova develops therapeutics for inflammatory diseases and neurological disorders, including cerebral stroke, traumatic brain injury, Alzheimer's and sepsis. | Location Durham | |
Company Relevant Biosciences Inc. | Activity: Research and Development | Company Description Relevant Bio develops natural antibody-based cancer therapeutics. | Location Raleigh | |
Company Renovion Inc. | Activity: Research and Development | Company Description Renovion is a clinical stage company developing therapies for chronic inflammatory lung diseases, including bronchiectasis, BOS in lung transplant and chronic bronchitis. | Location Chapel Hill | |
Company Reselute Inc. | Activity: Research and Development | Company Description Reselute is developing a medical device for the treatment of orthopedic implant related infections. | Location Durham | |
Company Resilient Biotics Inc. | Activity: Research and Development | Company Description Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. Resilient utilizes a proprietary discovery platform for product development and has a broad pipeline across multiple species. | Location Durham | |
Company Resonantia Diagnostics | Activity: Research and Development | Company Description Resonantia Diagnostics is a startup developing a point of care diagnostic platform that rapidly identifies a pathogen from a clinical specimen and determines the pathogen's antimicrobial susceptibility. | Location Durham | |
Company Revivo Therapeutics Inc. | Activity: Research and Development | Company Description Revivo Therapeutics is a clinical stage company developing therapies for cognitive dysfunction and neuroprotection. | Location Durham | |
Company RhizeBio LLC | Activity: Research and Development | Company Description RhizeBio uses systems biology to develop technology to optimize soil microbiota function and increase crops' fertility and genetic potential. | Location Mount Holly | |
Company Ribometrix Inc. | Activity: Research and Development | Company Description Ribometrix is developing a new class of small-molecule therapeutics that directly target and modulate the function of RNA to treat human diseases. | Location Durham | |
Company Rilento Pharma LLC | Activity: Research and Development | Company Description Rilento Pharma is a preclinical stage drug delivery company developing non-addictive oral surgery pain management technologies that are synchronized with the biologic process of wound healing. | Location Raleigh | |
Company Roivant Sciences Inc. | Activity: Research and Development | Company Description Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease. | Location Durham | |
Company Roke Biotechnologies LLC | Activity: Research and Development | Company Description Roke Biotechnologies develops novel 2-stage protein expression and purification technologies for making proteins used in research and in the industrial and pharmaceutical industries. | Location Durham | |
Company RT Cardiac Systems Inc. | Activity: Research and Development | Company Description RT Cardiac Systems is developing a proprietary blood pump technology for acute circulatory support to improve and advance therapy for high-risk percutaneous coronary intervention (HR PCI) and emergent heart failure. | Location Raleigh | |
Company Salvus LLC | Activity: Research and Development | Company Description Salvus provides a handheld chemical and biological interferometric detector, a device which has the ability to rapidly identify chemicals, pathogens and viruses in liquid, air or surface environments. | Location Charlotte | |
Company Sapere Bio Inc. | Activity: Research and Development | Company Description Sapere Bio develops biomarkers of aging for clinical use to help physicians predict risk of chemotherapy-induced toxicities and surgery-associated adverse events in various patient groups. | Location Research Triangle Park | |
Company Sarepta Therapeutics Inc. (Durham) | Activity: Research and Development | Company Description Sarepta Therapeutics develops precision genetic medicine treatments for Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD) and other central nervous system (CNS) disorders. Sarepta's Gene Editing Innovation Center is in Durham. | Location Durham | |
Company Satsuma Pharmaceuticals Inc. | Activity: Research and Development | Company Description Satsuma Pharmaceuticals is developing best-in-class intranasal drug products to address the significant unmet medical needs of acute migraine sufferers. | Location Durham | |
Company Scientific Purity LLC | Activity: Research and Development | Company Description Scientific Purity is developing more nutritious plants for consumers. | Location Bunn | |
Company SelSym Biotech Inc. | Activity: Research and Development | Company Description SeySym Biotech develops novel biomimetic materials for treating hemorrhage following trauma and surgery. | Location Durham | |
Company Sentiens LLC | Activity: Research and Development | Company Description Sentiens develops nutraceutical products targeting addictive behavior. | Location Charlotte | |
Company Shattuck Labs Inc. | Activity: Research and Development | Company Description Shattuck Labs is a preclinical-stage immunotherapy company focused on utilizing its proprietary ARC (Agonist Redirected Checkpoint) technology to develop novel treatments for use in cancer, inflammation and orphan disease. | Location Durham | |
Company SIF Biopharma LLC | Activity: Research and Development | Company Description SIF Biopharma develops new therapies in the areas of regenerative medicine and cancer. | Location Chapel Hill | |
Company SiNON Nano Sciences Inc. | Activity: Research and Development | Company Description SiNON is developing technology to treat neurological diseases by increasing the ability of drugs to cross the blood brain barrier (BBB). | Location Durham | |
Company Sipcam Agro USA Inc. | Activity: Research and Development | Company Description SipcamAdvan develops and manufactures herbicides, pesticides, fungicides and biocides. | Location Durham | |
Company Sirtsei Pharmaceuticals Inc. | Activity: Research and Development | Company Description Sirtsei Pharmaceuticals is developing a product for depression and schizophrenia. | Location Morrisville | |
Company Sloan Biologics LLC | Activity: Research and Development | Company Description Sloan Biologics is developing therapies to enhance the health of farms and the communities that support them. | Location Statesville | |
Company SNP Therapeutics LLC | Activity: Research and Development | Company Description SNP Therapeutics develops genetic tests to identify genetic variant patterns that contribute to disease. SNPT also designs nutritional therapeutics to treat metabolic disorders. | Location Kannapolis | |
Company Sobi (Durham) | Activity: Research and Development | Company Description Sobi develops treatments for orphan diseases with a focus on inflammation and genetic diseases. | Location Durham | |
Company Soil Health Institute | Activity: Research and Development | Company Description The Soil Health Institute partners with stakeholders to safeguard and enhance the vitality and productivity of soil through scientific research and advancement. | Location Morrisville | |
Company Solve Therapeutics Inc. | Activity: Research and Development | Company Description Solve Therapeutics develops antibody-drug conjugates (ADC) and antibody-radionuclide conjugates (ARC) for oncology patients. | Location Durham | |
Company Sonokine Bioscience Inc. | Activity: Research and Development | Company Description Sonokine Biosciences is developing cancer treatments that use high intensity focused ultrasound in combination with targeted delivery of immune therapies. | Location Chapel Hill | |
Company SonoVascular Inc. | Activity: Research and Development | Company Description SonoVascular has developed a novel pharmaco-mechanical ultrasound facilitated thrombectomy system that utilizes microbubble-mediated cavitation as a core enabling mechanism of action to more effectively treat deep vein thrombosis and pulmonary embolism. | Location Chapel Hill | |
Company SonoVol Inc | Activity: Research and Development | Company Description SonoVol has developed a preclinical imaging technology that can be applied to in vivo models that researchers use to evaluate the efficacy and toxicity of new drugs before they enter clinical trials. | Location Durham | |
Company SoyMeds Inc. | Activity: Research and Development | Company Description SoyMeds uses soybeans as a host to develop protein-based targets that can be used to diagnose and treat disease. SoyMeds' lead candidates include thyroglobulin and autoimmune (MS and MG) antigens. | Location Charlotte | |
Company SP Innovations LLC | Activity: Research and Development | Company Description SP Innovations is developing a graft for irreparable rotator cuff tendon injuries. | Location Raleigh | |
Company Sparta Biomedical Inc. | Activity: Research and Development | Company Description Sparta Biomedical is developing cartilage-like implants to mimic the properties of native cartilage and address degeneration in joints. | Location Morrisville | |
Company Speedwell Bio LLC | Activity: Research and Development | Company Description Speedwell Bio develops novel molecular assays and reagents for research and clinical diagnostics. | Location Chapel Hill | |
Company SpringWorks Therapeutics LLC | Activity: Research and Development | Company Description SpringWorks Therapeutics develops standalone and combination therapies with a focus on rare diseases and oncology, including plexiform neurofibroma, desmoid tumors, RAS/RAF mutant solid tumors and CNS disorders. Its initial portfolio is from Pfizer. | Location Durham |